Kalaris Therapeutics, Inc. - Common Stock (KLRS)
4.3800
-0.2300 (-4.99%)
NASDAQ· Last Trade: Jul 17th, 7:54 PM EDT
Kalaris Therapeutics (NASDAQ: KLRS) stock jumps 18% after releasing expanded Phase 1a data for its AMD treatment, TH103.
Via Benzinga · July 17, 2026
Gainers Jasper Therapeutics (NASDAQ:JSPR) stock moved upwards by 19.2% to $0.92 during Friday's regular session. The company's market cap stands at $21.6 million. Kalaris Therapeutics (NASDAQ:KLRS) shares
Via Benzinga · July 17, 2026
As the regular session of the US market concludes on Wednesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · December 17, 2025
Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · December 17, 2025
Via Benzinga · November 12, 2025
Via Benzinga · October 6, 2025
Via Benzinga · October 2, 2025
Via Benzinga · September 16, 2025
Via Benzinga · September 12, 2025
Via Benzinga · September 4, 2025
Via Benzinga · September 3, 2025
Via Benzinga · August 28, 2025
Via Benzinga · August 28, 2025
